729 related articles for article (PubMed ID: 18700172)
1. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
Molloy ES; Calabrese LH
Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
[TBL] [Abstract][Full Text] [Related]
2. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies.
Calabrese LH; Molloy ES
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii64-5. PubMed ID: 19022817
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases.
Molloy ES; Calabrese LH
Arthritis Rheum; 2009 Dec; 60(12):3761-5. PubMed ID: 19950261
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies.
Molloy ES; Calabrese LH
Arthritis Rheum; 2012 Sep; 64(9):3043-51. PubMed ID: 22422012
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review.
Henegar CE; Eudy AM; Kharat V; Hill DD; Bennett D; Haight B
Lupus; 2016 May; 25(6):617-26. PubMed ID: 26743322
[TBL] [Abstract][Full Text] [Related]
7. The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era: Prevention and Management.
Molloy ES; Calabrese CM; Calabrese LH
Rheum Dis Clin North Am; 2017 Feb; 43(1):95-109. PubMed ID: 27890176
[TBL] [Abstract][Full Text] [Related]
8. [Progressive multifocal leukoencephalopathy in a patient following long-term immunosuppressive therapy for systemic lupus erythematosus].
Kappers MH; Swaak AJ; Zuidgeest DM; Dees A
Ned Tijdschr Geneeskd; 2006 Feb; 150(7):387-92. PubMed ID: 16523804
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus.
Kapoor T; Mahadeshwar P; Hui-Yuen J; Quinnies K; Tatonetti N; Gartshteyn Y; Guo C; Geraldino-Pardilla L; Askanase AD
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32513809
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.
Calabrese LH; Molloy ES; Huang D; Ransohoff RM
Arthritis Rheum; 2007 Jul; 56(7):2116-28. PubMed ID: 17599729
[No Abstract] [Full Text] [Related]
11. Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.
Nived O; Bengtsson AA; Jönsen A; Sturfelt G
Lupus; 2008 Nov; 17(11):1036-41. PubMed ID: 18852230
[TBL] [Abstract][Full Text] [Related]
12. [Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus].
Yukitake M
Brain Nerve; 2019 May; 71(5):493-505. PubMed ID: 31088998
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy in a minimally immunosuppressed patient with systemic lupus erythematosus treated with dapsone.
Stahl NI
J Rheumatol; 2008 Apr; 35(4):725-7. PubMed ID: 18398953
[No Abstract] [Full Text] [Related]
14. Progressive multifocal leukoencephalopathy and antipsoriatic drugs: assessing the risk of immunosuppressive treatments.
Di Lernia V
Int J Dermatol; 2010 Jun; 49(6):631-5. PubMed ID: 20618466
[TBL] [Abstract][Full Text] [Related]
15. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus.
Magnano MD; Bush TM; Herrera I; Altman RD
Semin Arthritis Rheum; 2006 Jun; 35(6):396-402. PubMed ID: 16765717
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature.
Pelosini M; Focosi D; Rita F; Galimberti S; Caracciolo F; Benedetti E; Papineschi F; Petrini M
Ann Hematol; 2008 May; 87(5):405-12. PubMed ID: 18064459
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
[TBL] [Abstract][Full Text] [Related]
18. [Progressive multifocal leukoencephalopathy as a result of immunosuppressive therapy].
Arbusow V; Strupp M; Samtleben W; Hatz H; Brückmann H; Brandt T
Dtsch Med Wochenschr; 1999 May; 124(21):653-6. PubMed ID: 10382545
[TBL] [Abstract][Full Text] [Related]
19. Review of progressive multifocal leukoencephalopathy and natalizumab.
Aksamit AJ
Neurologist; 2006 Nov; 12(6):293-8. PubMed ID: 17122725
[TBL] [Abstract][Full Text] [Related]
20. PML and rheumatology: the contribution of disease and drugs.
Molloy ES
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S28-32. PubMed ID: 22123931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
